Moving Toward Virtual Networks: Spotlight On Pfizer R&D
This article was originally published in PharmAsia News
Executive Summary
PERTH, Australia - Pfizer's Asia strategy will focus on building a virtual network of collaborations with leading contract research organizations and academic groups rather than building bricks-and-mortar R&D facilities